Sequencing Ovarian Cancer Treatments Remains Challenging
The future looks to be defined by essential clinical trials.
How to Double Clinical Trial Eligibility in Advanced Lung Cancer
Broader clinical trial criteria could nearly double the number of patients with advanced non-small cell lung cancer who are eligible to participate.
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer
